Venous Thromboembolism Treatment Market Size

Venous Thromboembolism Treatment Market Size

Venous Thromboembolism Treatment Market size exceeded USD 950 million in 2020 and is expected to expand at over 8.7% CAGR from 2021 to 2027. There is growing pervasiveness of cardiovascular diseases (CVD) and cancer owing to adoption of smoking, alcohol, increasing obesity rate, lack of physical activity and consumption of high cholesterol food. Vascular diseases and cancer patients possess high risk of having venous thromboembolism (VTE). Cancer patients have higher chance of developing blood clots with treatment procedures along with associated heredity.

Deep vein thrombosis is an ailment wherein blood clot is developed usually in the deep veins of the upper and lower limbs. These clots may travel through the circulation and get lodged in the lungs; leading to a condition known as pulmonary embolism (PE). This condition altogether known as venous thromboembolism (VTE), may be fatal and can potentially lead to death. Thus, VTE needs to be addressed on time. There are several treatment devices including filters, compression devices, thrombectomy systems among others that are used to treat VTE and with growing disease prevalence, their acceptance will potentially spur in the coming years.